$10 Million Investment to Boost InforSense Expansion
News Oct 10, 2006
InforSense Ltd. has announced that the Company has received an investment of $10 million led by two of its largest investors – Fleming Family & Partners Private Equity (FF&P) and Imperial Innovations Group plc (Imperial Innovations).
InforSense will use the investment to continue expanding its global footprint, accelerate product developments and additional application initiatives in both its current and new markets.
"We are pleased to have completed this round of strategic fund-raising and are grateful to FF&P, Imperial Innovations, Elaia Partners, Sitka Health Fund VCT Plc and all our other shareholders for their continued support," said Prof. Yike Guo, Founder and Chief Executive Officer of InforSense.
"With these funds, we are well positioned to increase our growth rate and capitalize on the current success of our business."
David Donnelly, CEO FF&P Private Equity, added, "FF&P Private Equity is delighted to continue to support InforSense."
"The investment is in line with FF&P’s philosophy of backing companies and management teams that are successfully delivering innovative technologies and products to the market. The Company is well placed to enjoy success in the years ahead."
"InforSense has shown tremendous growth in the last twelve months, with a rapidly growing customer base," said Susan Searle, CEO of Imperial Innovations.
"We are delighted to be able to support them as they continue that growth with our largest single investment to date."
Ingestible Drug-Delivery Materials May Improve Patient Treatment ComplianceNews
Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.READ MORE
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
Comments | 0 ADD COMMENT
6th Edition of International Conference on Pharmacognosy and Medicinal Plants
Apr 16 - Apr 17, 2018
International Conference and Exhibition on Nanomedicine and Nanotechnology
Nov 23 - Nov 24, 2017
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018